Biopharma

Gene Editing Gets Ready for the Spotlight

Pharma has invested billions in cell and gene therapies. Gene editing is making a case for more of this funding, but companies need to understand what they’re investing in and why.

Improving Care in Immune-Mediated Diseases

To become leaders in the field, biopharma companies must understand unmet needs and evolving standards of care and make greater use of real-world evidence.

Biopharma’s Role in Achieving Health Equity

Companies can take four steps to address the inequitable health outcomes that marginalized and underserved communities experience in the US.

Biopharma Is Betting Big on Digital and Data. Are Companies Organized for Success?

For their investments to pay off, biopharma companies need the right organizational setup and ways of working.

Health Care Payers, Providers, Systems, and Services

How Health Insurers Can Keep Talent and Cut Costs

A confluence of factors means the time-tested approaches to cost control won’t work. Insurers need to rethink how they achieve more with less while maintaining a strong customer focus and employee value proposition.

Price Transparency in US Health Care Demands Swift Action

A new regulation makes detailed pricing data widely available for the first time. Providers and insurers need to prepare now for a changed competitive playing field.

Health Care’s New Promise to Employees

An employee value proposition can help companies keep current employees and attract new ones.

In a Crowded Medicare Advantage Market, Know Thy Customer

As competition grows, plans need to win their members’ trust—and their renewal—every year. Here’s how to do it.

Medical Devices and Technology

Why Ottobock Leads with “Social” in ESG: An Interview with CEO Philipp Schulte-Noelle

A global leader in prostheses, Ottobock set out to also become the ESG leader in its field. The key: measuring the socioeconomic benefit of its products.

Monitoring Patient Health from Hospital to Home

When patients move through hospital units—and eventually are discharged—their vital information doesn’t follow. But smarter solutions can track patient data across settings.

For Cutting-Edge Innovations, the US Pulls Ahead of the EU in Medtech Regulation

A sea change is underway in how companies win regulatory approval for new health care products—particularly in the use of digital technology—and which markets they prioritize.

The Rise of the Next Generation of Medtech “Milkmen”

A next-generation commercial model is needed fast. Those who adopt it quickly will be rewarded handsomely.

Global Health

BCG Executive Perspectives: How to End the Global Pandemic in 2022

BCG Executive Perspectives offer insights on global topics that matter most to leaders in the public and private sectors. Our latest edition explores the evolving landscape of business and leisure travel, examining how companies within and beyond the industry can adapt to new trends.

Reimagining Global Health After the Coronavirus

What has worked, what can be improved, and what needs to be reimagined so that we are better prepared for the next pandemic and better able to improve health in the world’s poorest nations?

Play Video

What It Takes to Crush a Pandemic

BCG Managing Director & Partner Johanna Benesty looks at barriers to "equitable access"—making sure COVID-19 therapeutics are available to all—while sharing a creative approach to vaccine research and development.

• Anticipating the Spread of COVID-19 with Scenario Planning

  BCG’s scenario-planning tool, PLAN, helps you explore the potential impact of COVID-19 in the United States at a region, state, and county level.
• BD’s Vincent Forlenza on Transforming in a Rapidly Changing Industry

  Vincent Forlenza, CEO of BD, has navigated multibillion-dollar acquisitions while driving a full-scale organizational transformation. BD’s success, amid enormous change, hinges on its purpose-driven culture.
• Karalee Close on The Digital Opportunity in Healthcare

  Using digital to harness the next generation of science and the exponential growth of health care data.
• Accelerating Drug Development Today

  Sit in on a conversation with BCG pharma leaders as they discuss advancing drug development with new tools, real-world data, digitization, and collaboration across cross-functional teams.
• Using Big Data to Measure Health Care Outcomes

  According to BCG's Sanjay Saxena, the opportunity for using big data and analytics in measuring outcomes is huge. But the trick for payers and providers will be understanding the data—and knowing which questions to ask about it.
• Jon Kaplan on Health Care Payers

  BCG’s Jon Kaplan explains how health care payers can provide the strongest portfolio of product offerings and best service in today’s marketplace.